Pharmacy Groups Say Draft Medicaid FULs Could Lead To Rx Access Issues

Associations representing retail pharmacies say faults in CMS’ draft average manufacturer price-based federal upper limits for multiple source drugs could result in reduced access to drugs by the Medicaid population.